Edit
Porterhouse Medical Group
https://www.porterhousemedical.com/welcome/Last activity: 03.03.2025
Active
Porterhouse Medical provides medical and scientific insights and communication services to the global pharmaceutical industry, with a focus on programmes that have a positive and measurable impact for healthcare professionals and patients.
Our mission statement: “Developing a shared vision with our partners to deliver programmes to improve people’s lives” emphasises the way we work with our client partners to achieve their goals.
Our team is the perfect blend of science and creativity - including 9 PhDs/MScis, 5 medical doctors and a health economist. We are structured to offer excellence in strategic thinking, real-world insights, compelling content design, virtual and face-to-face meetings and events, and logistical support, with each client receiving the support of an integrated and dedicated team.
Our core values comprise our Porterhouse PATH; focusing on Passion, Ambition, Togetherness and Humour. They are built into our working lives and help contribute to our high-quality standards and strong relationships.
Our mission statement: “Developing a shared vision with our partners to deliver programmes to improve people’s lives” emphasises the way we work with our client partners to achieve their goals.
Our team is the perfect blend of science and creativity - including 9 PhDs/MScis, 5 medical doctors and a health economist. We are structured to offer excellence in strategic thinking, real-world insights, compelling content design, virtual and face-to-face meetings and events, and logistical support, with each client receiving the support of an integrated and dedicated team.
Our core values comprise our Porterhouse PATH; focusing on Passion, Ambition, Togetherness and Humour. They are built into our working lives and help contribute to our high-quality standards and strong relationships.
Location: United States, Pennsylvania, Reading
Employees: 51-200
Phone: +44 118 913 9100
Founded date: 2002
Investors 1
| Date | Name | Website |
| - | BioCity | biocity.co... |
Mentions in press and media 1
| Date | Title | Description |
| 03.03.2025 | Basel Medical Group Ltd Announces Closing of US$8,820,000 Initial Public Offering | Singapore, March 03, 2025 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (the “Company”) (Nasdaq: BMGL), a Singapore-based clinical provider of general and subspecialized orthopedic and trauma services, sports medicine and surgery, orthopedic ... |